Abstract
In the last few years, metabolism has been shown to be controlled by cross-organelle communication. The relationship between the endoplasmic reticulum and mitochondria/lysosomes is the most studied; here, inositol 1,4,5-triphosphate (IP3) receptor (IP3R)-mediated calcium (Ca2+) release plays a central role. Recent evidence suggests that IP3R isoforms participate in synthesis and degradation pathways. This minireview will summarize the current findings in this area, emphasizing the critical role of Ca2+ communication on organelle function as well as catabolism and anabolism, particularly in cancer.
Introduction
The life of a cell appears as an entanglement of complex networks of synthesis and degradation of molecules in a dynamic equilibrium essential for its viability (Muchowska et al., 2020). Within the cell, metabolic networks are completely intertwined, leading to the generation of special domains. Such domains contain a dynamic equilibrium of networks maintained by a series of regulators, particularly ions, such as calcium (Ca2+) (Bygrave, 1967).
Calcium is a regulator and cofactor of several fundamental cellular processes, including gene transcription, secretion, apoptosis, cell proliferation and differentiation, membrane excitability, motility, fertilization, autophagy, and metabolism (Berridge et al., 2000; Clapham, 2007). Inside the cell, Ca2+ is stored in several organelles, such as the endoplasmic reticulum (ER), mitochondria, nuclear envelope, Golgi apparatus, and lysosomes (Cárdenas et al., 2010a; La Rovere et al., 2016). The complex temporal and spatial control of Ca2+ communication between these organelles is achieved by several ion transporters and channels located in the membranes of these internal stores (Bootman and Bultynck, 2020). The main Ca2+ store of the cell is the ER (Berridge et al., 2003), which releases Ca2+ to the cytoplasm and other organelles, through ryanodine receptors (RyRs) (Lanner et al., 2010) and inositol 1,4,5-triphosphate (IP3) receptors (IP3Rs) (Mikoshiba, 2015). The RyRs display a rather limited tissue distribution, mainly in excitable cells such as neurons and myocytes (Shkryl, 2017), while IP3Rs are the most ubiquitous intracellular Ca2+ channels (Parys and De Smedt, 2012; Mak and Foskett, 2015).
Within organelles, Ca2+ plays additional roles regulating different aspects of organelle function, including metabolism. The regulatory role of Ca2+ on metabolic networks is supported by physical interactions between organelles that allow ion and molecule fluxes (Scorrano et al., 2019). These physical interactions have been defined as “membrane contact sites” (MCSs), which are highly dynamic interaction zones between two or more organelles characterized by close proximity between their membranes (10–80 nm), possessing specific functions and having a well-defined proteome and lipidome (Scorrano et al., 2019). So far, MCSs have been reported to be structural platforms for Ca2+ fluxes and to actively participate in intracellular signaling associated with autophagy, lipid metabolism, membrane dynamics, cellular stress response, organelle trafficking, and organelle biogenesis (Prinz et al., 2020).
Despite the above, knowledge about the regulation of metabolism by Ca2+ is still unknown in many aspects. The information about IP3R-mediated Ca2+ release in MCS and its possible implication is scarce. Thus, the role of IP3R in the MCS and how it may impact metabolism through mitochondria and lysosomes, along with its possible impact on cancer, will be reviewed.
IP3R: Structure, Isoforms, and Functions
Inositol 1,4,5-triphosphate (IP3) receptor is a family of three ligand-gated channels: type 1 IP3R (IP3R1), type 2 IP3R (IP3R2), and type 3 IP3R (IP3R3) (Prole and Taylor, 2019), each about 300 kDa and encoded by separate genes with around 70% homology in their amino acid sequences (Mikoshiba, 2007). The isoforms have the property of assembling into homo- or heterotetramers to form functional channels (Monkawa et al., 1995). They localize to the ER, Golgi (Bootman and Bultynck, 2020), nuclear envelope, and nucleoplasmic reticulum (Cárdenas et al., 2010a). The structure of the IP3R monomer can be divided into three functionally different domains (Boehning et al., 2001), among which there are two domains of high homology between the isoforms: the N-terminal domain with the ligand-binding pocket, including a suppressor region in addition to the IP3-binding core, and the C-terminal domain containing a pore region of six transmembrane helices forming the Ca2+ channel (Mikoshiba, 2007; Serysheva, 2014). The suppressor domain reduces the affinity of the IP3R for IP3 (Iwai et al., 2007); nevertheless, it is necessary for channel opening in response to its ligand (Uchida et al., 2003). The central cytosolic regulatory domain exhibits more sequence variability between subtypes and contains interaction sites for many intracellular regulators and interacting proteins (Patterson et al., 2004). The gatekeeper domain (residues 2590–2749 of IP3R1), also called the C-terminal coupling domain, is fundamental for the activity of the channel, as mutations in the domain or its interaction with antibodies results in a non-functional Ca2+ channel (Nakade et al., 1991; Uchida et al., 2003). This domain also serves as a binding place for several regulatory proteins (Foskett et al., 2007).
Inositol 1,4,5-triphosphate is produced by hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) in the cell membrane through phospholipase C (PLC) in response to extracellular stimuli such as hormones, growth factors, and neurotransmitters that bind to G-protein-coupled receptors (Cattaneo et al., 2014), as well as to receptor tyrosine kinases (Nakamura and Fukami, 2017). Every subunit of IP3R must be bound to IP3 to trigger the opening of the channel (Alzayady et al., 2016).
The regulators associated to Ca2+ release mediated by IP3R include free Ca2+ concentration in the cytosol (mentioned here as cytoplasmic Ca2+), as well as in the ER (mentioned here as reticular Ca2+), ATP, thiol modification, and phosphorylation by protein kinases (Boehning et al., 2001; Parys and De Smedt, 2012). Additionally, many different proteins can interact with the IP3R affecting its function (Patterson et al., 2004) like the anti-apoptotic B-cell lymphoma-2 (BCL-2) (Chen et al., 2004), BCL-XL (White et al., 2005), the myeloid cell leukemia 1 (MCL-1) (Eckenrode et al., 2010), the pro-autophagic Beclin 1 (Vicencio et al., 2009), Ca2+-dependent phospholipid-binding protein Annexin A1 (ANXA1) (Vais et al., 2020), IRBIT (Bonneau et al., 2016), and the ER stress sensor IRE1α (Carreras-Sureda et al., 2019).
Despite IP3R isoforms sharing a high level of sequence homology, they exhibit different properties. For example, they differ in affinity for IP3, which was established as IP3R2 > IP3R1 > IP3R3 (Prole and Taylor, 2019). Their differential modulation by cytosolic Ca2+ (Tu et al., 2005), ATP (Wagner and Yule, 2012), binding proteins (Higo et al., 2005), and post-translational modifications (Szado et al., 2008) shapes IP3R behavior in a subtype-specific manner. Additional complexity to IP3R-mediated Ca2+ signaling arises from splice variants (Nakagawa et al., 1991) and the fact that most cell types express two or three different isoforms (Wojcikiewicz, 1995) that may assemble into heterotetramers (Monkawa et al., 1995; Chandrasekhar et al., 2016).
The different isoforms show tissue- and cell-specific expression patterns, with one isoform often being predominantly expressed (Vermassen et al., 2004). For example, IP3R1 has a broad tissue distribution but is especially abundant in the cerebellum (and most of the central nervous system), where it was initially purified and characterized (Furuichi et al., 1993). It is also expressed in vascular smooth muscle cells, thyroid, uterus, and lymphocytes (DeSouza et al., 2007; Narayanan et al., 2012). IP3R2 is expressed in cardiac muscle, as well as liver, kidney, and other epithelial tissues (Klar et al., 2014), while IP3R3 is expressed in endothelial cells, testis, endocrine and exocrine pancreas, spleen, gastrointestinal tract, and thymus (De Smedt et al., 1997).
IP3R at the ER–Mitochondria MCS and Cellular Metabolism
The most characterized MCSs so far are the mitochondria–ER contact sites (MERCs) (Wu et al., 2018), which regulate many biological processes such as apoptosis, lipid synthesis, and early steps of autophagy, and several aspects of mitochondrial physiology, fusion–fission dynamics, biogenesis, and degradation (Gordaliza-Alaguero et al., 2019). The IP3R has been described as the most prevalent ER Ca2+ channel in MERCs. In those sites, the IP3R interacts with mitochondria through the voltage-dependent anion channels (VDACs) (Csordás et al., 2018). Additionally, it interacts with several adaptors such as the transglutaminase 2 (TG2) (D’Eletto et al., 2018), TOM70 (Filadi et al., 2018), and the glucose-regulated protein (Grp75) (Szabadkai et al., 2006; Honrath et al., 2017; Figure 1A). Finally, Ca2+ reaches the mitochondrial matrix through the channel mitochondrial calcium uniporter complex (MCUC), which interacts with many regulator proteins that affect its permeability to Ca2+ (De Stefani et al., 2016). The Ca2+ flux sustained by MERCs regulates mitochondrial metabolism and affects the activities of pyruvate dehydrogenase (PDH), isocitrate dehydrogenase (IDH), oxoglutarate dehydrogenase (OGDH), and electron transport chain (ETC) complexes III and V (Denton, 2009; Glancy and Balaban, 2012). If the ER–mitochondria Ca2+ flux is interrupted, p-AMPK levels increase, which, in turn, increases the activity of autophagy in a mTOR-independent manner (Cárdenas et al., 2010b, 2017). SIRT1 is also increased, which participates in the activation of autophagy (Cardenas et al., 2020; Figure 1A), and triggers mitochondrial fragmentation (Lovy et al., 2020). Autophagy is a process associated with degradative pathways of macromolecules, which generates monomeric metabolites that supply many metabolic pathways and in this manner maintain metabolic equilibrium and mitochondrial function (Rabinowitz and White, 2010; Guo et al., 2016; Ahumada-Castro et al., 2019). Additionally, the pro-autophagic protein Beclin-1 interacts with IP3R (Vicencio et al., 2009), and its lack of interaction induces autophagy, also contributing to regulating metabolism, but the mechanistic details are still unclear (Decuypere et al., 2011).
FIGURE 1
Furthermore, lipid accumulations associated with AMPK dephosphorylation have been observed in cellular models with inhibited MCU-dependent mitochondrial Ca2+ uptake. This is mediated by Ca2+-dependent protein phosphatase-4 (PP4) activity (Tomar et al., 2019). However, it remains mostly unclear to what extent lipid metabolism regulates IP3R-mediated Ca2+ fluxes or, vice versa, to what extent these Ca2+ fluxes regulate lipid metabolism via other intermediary proteins. Along these lines, proteins related to lipid transport have been described at the MERCS where they regulate Ca2+ flux between ER and mitochondria (Pulli et al., 2018). Moreover, a preprint from Giordano lab shows that oxysterol-binding protein-related proteins (ORP) 5 and 8 physically and functionally interact with MIB/MICOS complexes facilitating the transfer of phosphatidylserine (PS) from the ER to mitochondria (Rochin et al., 2019). In addition, ORP5 interacts with VDAC regulating the mitochondrial Ca2+ uptake at MERCS (Rochin et al., 2019; Figure 1A). Finally, ORP4L has been described extracting and presenting PIP2 to PLCβ3 (Zhong et al., 2019), facilitating IP3 generation. Also, ORP4L interaction with IP3R1 regulates its activity (Cao et al., 2019). Expectedly, all these interactions could cause mitochondrial bioenergetic alterations, involving additional metabolic pathways.
In all cases described above, it is not completely understood whether the IP3R isoforms contribute differently to this process. Recently, Bartok et al. (2019) clearly show that IP3R is necessary for ER–mitochondrial contact formation, and re-expression of each of the three isoforms alone was sufficient to restore the MERCs in triple IP3R-deficient (TKO) DT40 cells. Additionally, the authors show that IP3R2 turned out to be the most efficient isoform in delivering Ca2+ into mitochondria (Bartok et al., 2019). This result suggests that IP3R2 is essential for many aspects of cellular metabolism, but more studies need to be performed to clarify if this phenomenon observed in DT40 and HeLa can be extrapolated to other cell types and other physiological contexts.
B-cell lymphoma-2 protein family members, which also interact with the IP3R, have been shown to play a role in mitochondrial metabolism (Chong et al., 2020). In particular, BCL2 regulated oxidative phosphorylation (OXPHOS) at complex IV level (Chen and Pervaiz, 2010), BCL-XL regulated ATP synthase (Alavian et al., 2011), and MCL-1 regulated aspects of mitochondrial dynamics, mitochondrial physiology, and its metabolism (Perciavalle et al., 2012; Escudero et al., 2018; Figure 1A). In addition, TG2 and ANXA1 have been associated with glutamine metabolism (Figure 1A; Nurminskaya and Belkin, 2012) and regulation of reductive carboxylation, respectively (Rohwer et al., 2016). Whether these effects on metabolism are related to their interaction with IP3R and Ca2+ flux is unclear.
Finally, IRE1α, a protein related to ER homeostasis and its response to stress, particularly by the unfolded protein response (UPR) (Hetz et al., 2020), interacts with IP3R and plays a role in cellular metabolism (Figure 1A). Carreras-Sureda et al. (2019) described that IRE1α interacts with IP3R1, regulating IP3R-mediated Ca2+ release and its position in MERCS and in this manner regulates TCA cycle activity and MERCS. Although IRE1a has been described to regulate aspects of cellular metabolism such as lipid metabolism and glycolysis (Huang et al., 2019; Figure 1A), it is not clear whether this regulation is also mediated by IP3R-mediated Ca2+.
IP3R at the ER–Lysosome MCS and Celullar Metabolism
In a similar way to MERCs, ER establishes membrane contact sites with lysosomes and endosomes, but these have not been completely characterized (Lee and Blackstone, 2020). A stable interaction between ER and early/late endosomes, probably related to the maturation process of these vesicles, has been shown (Friedman et al., 2011; Zajac et al., 2013). In addition, Ca2+ fluxes between these two organelles have been described. In fact, the ER is the most important source of lysosomal Ca2+, which can be delivered by all three IP3R isoforms (Atakpa et al., 2018; Figure 1B). This Ca2+ has been described as one of the counterions that the lysosome utilizes for its acidification (Christensen et al., 2002; Yang et al., 2019). Furthermore, changes in lysosomal pH generate a redistribution of lysosomes toward other areas of the ER with a lower density of IP3Rs, which finally interrupts this Ca2+ flow (Atakpa et al., 2018). Along with this, autophagy can be regulated by the release of lysosomal Ca2+ stores to cytoplasm, inducing the activity of calcineurin, a Ca2+-dependent phosphatase, which dephosphorylates the transcription factor EB (TFEB) and allows its translocation to the nucleus (Medina et al., 2015; Figure 1B). TFEB is a master regulator of the coordinated lysosomal expression and regulation (CLEAR) network, a gene network associated with the lysosome and autophagy (Palmieri et al., 2011). Another interesting fact described by Cang et al. (2013) pertains to the role of two pore channels (TPCs) on cellular metabolism. TPCs are endosome/lysosome-located ion channels selective to sodium (Na+) and Ca2+ that form a complex with mTOR. Upon starvation, when mTOR is inhibited, TPCs are actively transferring Ca2+ to the lysosome, which is necessary to maintain the lysosomal pH and amino acid efflux (Cang et al., 2013). Whether IP3R-mediated Ca2+ release to lysosomes plays a role in its degradative activity or in cellular metabolism is unknown. Interestingly, Peng et al. (2020) have described the occurrence of Ca2+ fluxes between lysosomes and mitochondria, via the lysosomal ion channel MCOLN1 and the mitochondrial transporter VDAC (Figure 1B). Such a discovery opened a new path to target Ca2+ regulation of mitochondrial metabolism for therapeutic purposes. Finally, cholesterol transfer between ER and lysosomes has been described, possibly having implications on low-density lipoprotein (LDL) metabolism (Höglinger et al., 2019). This transfer involves the cholesterol sensor oxysterol-binding protein-related protein 1L (ORP1L) and the integral ER proteins VAPA/B proteins (Höglinger et al., 2019). Certainly, the relationships between Ca2+ and lipids associated to lysosomes have been shown before (Van Der Kant and Neefjes, 2014); however, it is still unclear if IP3R Ca2+ release is involved.
Implications in Cancer
For oncogenic processes, the rewiring of metabolic networks is an essential step (De Berardinis and Chandel, 2016). Many cancer hallmarks such as migration, invasion, excessive proliferation, apoptosis evasion, and angiogenesis, among others, are sustained by altered metabolism (Ward and Thompson, 2012). Alterations can be evidenced as changes in nutrient consumption (increase glutamine utilization) (Cluntun et al., 2017), changes in mitochondria to favor lipid and nucleotide synthesis to support growth (DeBerardinis et al., 2008), and generation of oncometabolites that favor proliferation and invasion of cancer cells (Sciacovelli and Frezza, 2016).
In all these instances, metabolic rewiring is coupled with modifications of Ca2+ fluxes, particularly those involving the ER Ca2+ store (Zhai et al., 2020). It has been described that pancreatic (Okeke et al., 2016), breast (Singh et al., 2017), colorectal (Pierro et al., 2014), glioblastoma (Kang et al., 2017), gastric (Sakakura et al., 2003), and lung cancers (Bergner et al., 2009) show increases in IP3R isoform levels, IP3R3 being the preponderant isoform (Rezuchova et al., 2019; Rosa et al., 2020), followed by IP3R2 (Vervloessem et al., 2014; Bartok et al., 2019). It could be speculated that these cells have a better mitochondrial metabolism fitness and lysosomal function that provide them with a proliferative and survival advantage.
Additionally, our group has described that cancer cells become “addicted to IP3R-mediated Ca2+ release,” which is essential for cancer cell survival (Cárdenas et al., 2017; Cardenas et al., 2020). In this context, it is interesting to note that many anti-apoptotic proteins, such as BCL2, BCL-XL, and MCL1, which are essential for the oncogenic processes, work as IP3R regulators. In addition, oncogenic proteins such as AKT, PML, and PTEN modify IP3R function. AKT, which is overactivated in many cancers, inhibits IP3R-mediated Ca2+ release (Marchi et al., 2012). Mutated PML (as is normally found in cancers) loses its ability to increase IP3R-mediated Ca2+ release (Missiroli et al., 2016). Finally, PTEN (Kuchay et al., 2017) increases IP3R-mediated Ca2+ release through its phosphatase activity. Currently, it is known and well accepted that IP3R-mediated Ca2+ fluxes in cancer are essential for cancer development, but whether specific changes in IP3R isoform patterns occur in different types of cancer has not been studied.
Concluding Remarks/Perspectives
Cancer is a pathology like no other due to the presence of several layers of heterogeneity, which include different tissues and different oncogenic processes (Gerlinger et al., 2012; Venkatesan and Swanton, 2016). For these reasons, the search and development of new drugs capable to cure many types of cancers have been long and difficult. Cellular metabolism appears as a good target to tackle several types of cancer and its regulation by Ca2+ seems to be a good option to develop new drugs (Bustos et al., 2017). Regarding Ca2+, there is accumulated knowledge about the specific role of many ion channels in cancer cell physiology (Marchi et al., 2020). In this context, Xestospongin B (XeB), an alkaloid obtained from the marine sponge Xestospongia exigua, specifically inhibits IP3R-mediated Ca2+ release (Jaimovich et al., 2005), selectively inducing non-apoptotic cell death of some types of cancer cells (Cárdenas et al., 2017; Cardenas et al., 2020). In this case, Ca2+ flux interruption leads cancer cells into a metabolic and bioenergetic crisis that ends in cell death (Silva-Pavez et al., 2020). Other Xestospongins have been tested too, but they are not as selective as XeB (Gambardella et al., 2020). Similarly, the inhibition of the IP3 generation by ORP4L with the compound LYZ-81 has been shown to eradicate leukemia stem cells in a selective manner (Zhong et al., 2019). Another molecule tested to blunt the activity of the IP3R is the non-specific inhibitor, 2-aminoethoxydiphenyl borate (2APB), which induces apoptosis in gastric cancer cells through an unexplored mechanism (Sakakura et al., 2003). Along with the three cases mentioned above, there are other molecules that have been developed as IP3R inhibitors that need to be tested as potential anti-tumor drugs (Gambardella et al., 2020). On the other hand, several molecules and peptides have been tested and shown to activate IP3R-mediated Ca2+ release generating an overwhelming transfer of Ca2+ to mitochondria. These high Ca2+ concentrations induce apoptosis or sensitize cancer cells to chemotherapeutic drugs such as Bcl-2/IP3R Disruptor-2 (BIRD-2), which is a peptide (Bittremieux et al., 2019), and GGTi-2418, a geranylgeranyl transferase inhibitor of FBXL2 (Kuchay et al., 2017).
In all cases mentioned above, IP3Rs have emerged as essential Ca2+ channels for cancer cell survival. How different IP3R isoforms – homotetramers or heterotetramers – contribute to cancer development remains an area of research that requires more exploration. A better understanding of IP3R regulation and its effects on metabolism in normal and cancer cells will help to develop new therapeutic strategies to fight this devastating set of diseases in the future.
Statements
Author contributions
UA-C and CC designed and outlined the structure and contents of the review. UA-C, GB, ES-P, AP-H, AL, and CC contributed to the literature review, discussion, and writing of the manuscript. All authors contributed to manuscript revision and approved the version to be published.
Funding
This work was supported by the ANID/FONDECYT # 1200255 (CC) and ANID/FONDAP #15150012 (UA-C, CC, and AL).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
Ahumada-CastroU.Silva-PavezE.LovyA.PardoE.MolgüJ.CárdenasC. (2019). MTOR-independent autophagy induced by interrupted endoplasmic reticulum-mitochondrial Ca2+ communication: a dead end in cancer cells.Autophagy15358–361. 10.1080/15548627.2018.1537769
2
AlavianK. N.LiH.CollisL.BonanniL.ZengL.SacchettiS.et al (2011). Bcl-x L regulates metabolic efficiency of neurons through interaction with the mitochondrial F1 FO ATP synthase.Nat. Cell Biol.131224–1233. 10.1038/ncb2330
3
AlzayadyK. J.WangL.ChandrasekharR.WagnerL. E.Van PetegemF.YuleD. I. (2016). Defining the stoichiometry of inositol 1,4,5-trisphosphate binding required to initiate Ca2+ release.Sci. Signal.9:ra35. 10.1126/scisignal.aad6281
4
AtakpaP.ThillaiappanN. B.MataragkaS.ProleD. L.TaylorC. W. (2018). IP3 receptors preferentially associate with ER-lysosome contact sites and selectively deliver Ca2+ to lysosomes.Cell Rep.253180–3193. 10.1016/j.celrep.2018.11.064
5
BartokA.WeaverD.GolenárT.NichtovaZ.KatonaM.BánsághiS.et al (2019). IP3 receptor isoforms differently regulate ER-mitochondrial contacts and local calcium transfer.Nat. Commun.10:3726. 10.1038/s41467-019-11646-3
6
BergnerA.KellnerJ.TufmanA.HuberR. M. (2009). Endoplasmic reticulum Ca2+-homeostasis is altered in small and non-small cell lung cancer cell lines.J. Exp. Clin. Cancer Res.2825. 10.1186/1756-9966-28-25
7
BerridgeM. J.BootmanM. D.RoderickH. L. (2003). Calcium signalling: dynamics, homeostasis and remodelling.Nat. Rev. Mol. Cell Biol.4517–529. 10.1038/nrm1155
8
BerridgeM. J.LippP.BootmanM. D. (2000). The versatility and universality of calcium signalling.Nat. Rev. Mol. Cell Biol.111–21. 10.1038/35036035
9
BittremieuxM.La RovereR. M.AklH.MartinesC.WelkenhuyzenK.DubronK.et al (2019). Constitutive IP 3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP 3 receptor disruptor BIRD-2.Cell Death Differ.26531–547. 10.1038/s41418-018-0142-3
10
BoehningD.MakD. O. D.FoskettJ. K.JosephS. K. (2001). Molecular determinants of ion permeation and selectivity in inositol 1,4,5-trisphosphate receptor Ca2+ channels.J. Biol. Chem.27613509–13512. 10.1074/jbc.C100094200
11
BonneauB.AndoH.KawaaiK.HiroseM.Takahashi-IwanagaH.MikoshibaK. (2016). IRBIT controls apoptosis by interacting with the Bcl-2 homolog, Bcl2l10, and by promoting ER-mitochondria contact.eLife5:e19896. 10.7554/eLife.19896
12
BootmanM. D.BultynckG. (2020). Fundamentals of cellular calcium signaling: a primer.Cold Spring Harb. Perspect. Biol.12:a038802. 10.1101/cshperspect.a038802
13
BustosG.CruzP.LovyA.CárdenasC. (2017). Endoplasmic reticulum-mitochondria calcium communication and the regulation of mitochondrial metabolism in cancer, a novel potential target.Front. Oncol.7:199. 10.3389/fonc.2017.00199/abstract
14
BygraveF. L. (1967). The ionic environment and metabolic control.Nature214667–671. 10.1038/214667a0
15
CangC.ZhouY.NavarroB.SeoY. J.ArandaK.ShiL.et al (2013). MTOR regulates lysosomal ATP-sensitive two-pore Na+ channels to adapt to metabolic state.Cell152778–790. 10.1016/j.cell.2013.01.023
16
CaoX.ChenJ.LiD.XieP.XuM.LinW.et al (2019). ORP4L couples IP3 to ITPR1 in control of endoplasmic reticulum calcium release.FASEB J.3313852–13865. 10.1096/fj.201900933RR
17
CárdenasC.EscobarM.GarcíaA.Osorio-ReichM.HärtelS.FoskettJ. K.et al (2010a). Visualization of inositol 1,4,5-trisphosphate receptors on the nuclear envelope outer membrane by freeze-drying and rotary shadowing for electron microscopy.J. Struct. Biol.171372–381. 10.1016/j.jsb.2010.05.003
18
CardenasC.LovyA.Silva-PavezE.UrraF.MizzoniC.Ahumada-CastroU.et al (2020). Cancer cells with defective oxidative phosphorylation require endoplasmic reticulum-to-mitochondria Ca2+transfer for survival.Sci. Signal.13:eaay1212. 10.1126/scisignal.aay1212
19
CárdenasC.MillerR. A.SmithI.BuiT.MolgoJ.MullerM.et al (2010b). Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria.Cell142270–283. 10.1016/j.cell.2010.06.007
20
CárdenasC.MüllerM.McNealA.LovyA.JaňaF.BustosG.et al (2017). Selective vulnerability of cancer cells by inhibition of Ca2+ transfer from endoplasmic reticulum to mitochondria.Cell Rep.142313–2324. 10.1016/j.celrep.2016.02.030
21
Carreras-SuredaA.JañaF.UrraH.DurandS.MortensonD. E.SagredoA.et al (2019). Non-canonical function of IRE1α determines mitochondria-associated endoplasmic reticulum composition to control calcium transfer and bioenergetics.Nat. Cell Biol.21755–767. 10.1038/s41556-019-0329-y
22
CattaneoF.GuerraG.ParisiM.De MarinisM.TafuriD.CinelliM.et al (2014). Cell-surface receptors transactivation mediated by G protein-coupled receptors.Int. J. Mol. Sci.1519700–19728. 10.3390/ijms151119700
23
ChandrasekharR.AlzayadyK. J.WagnerL. E.YuleD. I. (2016). Unique regulatory properties of heterotetrameric inositol 1,4, 5-trisphosphate receptors revealed by studying concatenated receptor constructs.J. Biol. Chem.2914846–4860. 10.1074/jbc.M115.705301
24
ChenR.ValenciaI.ZhongF.McCollK. S.RoderickH. L.BootmanM. D.et al (2004). Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate.J. Cell Biol.166193–203. 10.1083/jcb.200309146
25
ChenZ. X.PervaizS. (2010). Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2.Cell Death Differ.17408–420. 10.1038/cdd.2009.132
26
ChongS. J. F.MarchiS.PetroniG.KroemerG.GalluzziL.PervaizS. (2020). Noncanonical cell fate regulation by Bcl-2 proteins.Trends Cell Biol.30537–555. 10.1016/j.tcb.2020.03.004
27
ChristensenK. A.MyersJ. T.SwansonJ. A. (2002). pH-dependent regulation of lysosomal calcium in macrophages.J. Cell Sci.115599–607.
28
ClaphamD. E. (2007). Calcium signaling.Cell1311047–1058. 10.1016/j.cell.2007.11.028
29
CluntunA. A.LukeyM. J.CerioneR. A.LocasaleJ. W. (2017). Glutamine metabolism in cancer: understanding the heterogeneity.Trends Cancer3169–180. 10.1016/j.trecan.2017.01.005
30
CsordásG.WeaverD.HajnóczkyG. (2018). Endoplasmic reticulum–mitochondrial contactology: structure and signaling functions.Trends Cell Biol.28523–540. 10.1016/j.tcb.2018.02.009
31
De BerardinisR. J.ChandelN. S. (2016). Fundamentals of cancer metabolism.Sci. Adv.2:e1600200. 10.1126/sciadv.1600200
32
De SmedtH.MissiaenL.ParysJ. B.HenningR. H.SienaertI.VanlingenS.et al (1997). Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin.Biochem. J.322575–583. 10.1042/bj3220575
33
De StefaniD.RizzutoR.PozzanT. (2016). Enjoy the trip: calcium in mitochondria back and forth.Annu. Rev. Biochem.85161–192. 10.1146/annurev-biochem-060614-034216
34
DeBerardinisR. J.LumJ. J.HatzivassiliouG.ThompsonC. B. (2008). The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.Cell Metab.711–20. 10.1016/j.cmet.2007.10.002
35
DecuypereJ. P.WelkenhuyzenK.LuytenT.PonsaertsR.DewaeleM.MolgóJ.et al (2011). Ins(1,4,5)P3 receptor-mediated Ca2+ signaling and autophagy induction are interrelated.Autophagy71472–1489. 10.4161/auto.7.12.17909
36
D’ElettoM.RossinF.OcchigrossiL.FarraceM. G.FaccendaD.DesaiR.et al (2018). Transglutaminase type 2 regulates ER-mitochondria contact sites by interacting with GRP75.Cell Rep.253573–3581. 10.1016/j.celrep.2018.11.094
37
DentonR. M. (2009). Regulation of mitochondrial dehydrogenases by calcium ions.Biochim. Biophys. Acta17871309–1316. 10.1016/j.bbabio.2009.01.005
38
DeSouzaN.CuiJ.DuraM.McDonaldT. V.MarksA. R. (2007). A function for tyrosine phosphorylation of type 1 inositol 1,4,5-trisphosphate receptor in lymphocyte activation.J. Cell Biol.179923–934. 10.1083/jcb.200708200
39
EckenrodeE. F.YangJ.VelmuruganG. V.Kevin FoskettJ.WhiteC. (2010). Apoptosis protection by Mcl-1 and Bcl-2 modulation of inositol 1,4,5-trisphosphate receptor-dependent Ca2+ signaling.J. Biol. Chem.28513678–13684. 10.1074/jbc.M109.096040
40
EscuderoS.ZaganjorE.LeeS.MillC. P.MorganA. M.CrawfordE. B.et al (2018). Dynamic regulation of long-chain fatty acid oxidation by a noncanonical interaction between the MCL-1 BH3 Helix and VLCAD.Mol. Cell69729–743. 10.1016/j.molcel.2018.02.005
41
FiladiR.LealN. S.SchreinerB.RossiA.DentoniG.PinhoC. M.et al (2018). TOM70 sustains cell bioenergetics by promoting IP3R3-mediated ER to mitochondria Ca2+ transfer.Curr. Biol.28369–382. 10.1016/j.cub.2017.12.047
42
FoskettJ. K.WhiteC.CheungK. H.MakD. O. D. (2007). Inositol trisphosphate receptor Ca2+ release channels.Physiol. Rev.87593–658. 10.1152/physrev.00035.2006
43
FriedmanJ. R.LacknerL. L.WestM.DiBenedettoJ. R.NunnariJ.VoeltzG. K. (2011). ER tubules mark sites of mitochondrial division.Science334358–362. 10.1126/science.1207385
44
FuruichiT.Simon-ChazottesD.FujinoI.YamadaN.HasegawaM.MiyawakiA.et al (1993). Widespread expression of inositol 1,4,5-trisphosphate receptor type 1 gene (Insp3r1) in the mouse central nervous system.Recept. Channels111–24.
45
GambardellaJ.MorelliM. B.WangX.CastellanosV.MoneP.SantulliG. (2020). The discovery and development of IP3 receptor modulators: an update.Expert Opin. Drug Discov.1–10. 10.1080/17460441.2021.1858792
46
GerlingerM.RowanA. J.HorswellS.LarkinJ.EndesfelderD.GronroosE.et al (2012). Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.N. Engl. J. Med.366883–892. 10.1056/NEJMoa1113205
47
GlancyB.BalabanR. S. (2012). Role of mitochondrial Ca2+ in the regulation of cellular energetics.Biochemistry512959–2973. 10.1021/bi2018909
48
Gordaliza-AlagueroI.CantóC.ZorzanoA. (2019). Metabolic implications of organelle–mitochondria communication.EMBO Rep.20:e47928. 10.15252/embr.201947928
49
GuoJ. Y.TengX.LaddhaS. V.MaS.Van NostrandS. C.YangY.et al (2016). Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells.Genes Dev.301704–1717. 10.1101/gad.283416.116
50
HetzC.ZhangK.KaufmanR. J. (2020). Mechanisms, regulation and functions of the unfolded protein response.Nat. Rev. Mol. Cell Biol.21421–438. 10.1038/s41580-020-0250-z
51
HigoT.HattoriM.NakamuraT.NatsumeT.MichikawaT.MikoshibaK. (2005). Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44.Cell12085–98. 10.1016/j.cell.2004.11.048
52
HöglingerD.BurgoyneT.Sanchez-HerasE.HartwigP.ColacoA.NewtonJ.et al (2019). NPC1 regulates ER contacts with endocytic organelles to mediate cholesterol egress.Nat. Commun.10:4276. 10.1038/s41467-019-12152-2
53
HonrathB.MetzI.BendridiN.RieussetJ.CulmseeC.DolgaA. M. (2017). Glucose-regulated protein 75 determines ER–mitochondrial coupling and sensitivity to oxidative stress in neuronal cells.Cell Death Discov.3:17076. 10.1038/cddiscovery.2017.76
54
HuangS.XingY.LiuY. (2019). Emerging roles for the ER stress sensor IRE1 in metabolic regulation and disease.J. Biol. Chem.29418726–18741. 10.1074/jbc.REV119.007036
55
IwaiM.MichikawaT.BosanacI.IkuraM.MikoshibaK. (2007). Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors.J. Biol. Chem.28212755–12764. 10.1074/jbc.M609833200
56
JaimovichE.MatteiC.LiberonaJ. L.CardenasC.EstradaM.BarbierJ.et al (2005). Xestospongin B, a competitive inhibitor of IP3-mediated Ca 2+ signalling in cultured rat myotubes, isolated myonuclei, and neuroblastoma (NG108-15) cells.FEBS Lett.5792051–2057. 10.1016/j.febslet.2005.02.053
57
KangS.HongJ.LeeJ. M.MoonH. E.JeonB.ChoiJ.et al (2017). Trifluoperazine, a well-known antipsychotic, inhibits glioblastoma invasion by binding to calmodulin and disinhibiting calcium release channel IP3R.Mol. Cancer Ther.16217–227. 10.1158/1535-7163.MCT-16-0169-T
58
KlarJ.HisatsuneC.BaigS. M.TariqM.JohanssonA. C. V.RasoolM.et al (2014). Abolished InsP3R2 function inhibits sweat secretion in both humans and mice.J. Clin. Invest.1244773–4780. 10.1172/JCI70720
59
KuchayS.GiorgiC.SimoneschiD.PaganJ.MissiroliS.SarafA.et al (2017). PTEN counteracts FBXL2 to promote IP3R3- and Ca 2+ -mediated apoptosis limiting tumour growth.Nature546554–558. 10.1038/nature22965
60
La RovereR. M. L.RoestG.BultynckG.ParysJ. B. (2016). Intracellular Ca2+ signaling and Ca2+ microdomains in the control of cell survival, apoptosis and autophagy.Cell Calc.6074–87. 10.1016/j.ceca.2016.04.005
61
LannerJ. T.GeorgiouD. K.JoshiA. D.HamiltonS. L. (2010). Ryanodine receptors: structure, expression, molecular details, and function in calcium release.Cold Spring Harb. Perspect. Biol.21–21. 10.1101/cshperspect.a003996
62
LeeC. A.BlackstoneC. (2020). ER morphology and endo-lysosomal crosstalk: functions and disease implications.Biochim. Biophys. Acta Mol. Cell Biol. Lipids1865:158544. 10.1016/j.bbalip.2019.158544
63
LovyA.Ahumada-CastroU.BustosG.FariasP.Gonzalez-BillaultC.MolgóJ.et al (2020). Concerted action of AMPK and Sirtuin-1 induces mitochondrial fragmentation upon inhibition of Ca2+ transfer to mitochondria.Front. Cell Dev. Biol.8:378. 10.3389/fcell.2020.00378
64
MakD. O. D.FoskettJ. K. (2015). Inositol 1,4,5-trisphosphate receptors in the endoplasmic reticulum: a single-channel point of view.Cell Calc.5867–78. 10.1016/j.ceca.2014.12.008
65
MarchiS.GiorgiC.GalluzziL.PintonP. (2020). Ca2+ fluxes and cancer.Mol. Cell781055–1069. 10.1016/j.molcel.2020.04.017
66
MarchiS.MarinelloM.BononiA.BonoraM.GiorgiC.RimessiA.et al (2012). Selective modulation of subtype III IP3R by Akt regulates ER Ca2+ release and apoptosis.Cell Death Dis.3:e304. 10.1038/cddis.2012.45
67
MedinaD. L.Di PaolaS.PelusoI.ArmaniA.De StefaniD.VendittiR.et al (2015). Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB.Nat. Cell Biol.17288–299. 10.1038/ncb3114
68
MikoshibaK. (2007). IP3 receptor/Ca2+ channel: from discovery to new signaling concepts.J. Neurochem.1021426–1446. 10.1111/j.1471-4159.2007.04825.x
69
MikoshibaK. (2015). Role of IP3 receptor signaling in cell functions and diseases.Adv. Biol. Regul.57217–227. 10.1016/j.jbior.2014.10.001
70
MissiroliS.BonoraM.PatergnaniS.PolettiF.PerroneM.GafàR.et al (2016). PML at mitochondria-associated membranes is critical for the repression of autophagy and cancer development.Cell Rep.162415–2427. 10.1016/j.celrep.2016.07.082
71
MonkawaT.MiyawakiA.SugiyamaT.YoneshimaH.Yamamoto-HinoM.FuruichiT.et al (1995). Heterotetrameric complex formation of inositol 1,4,5-trisphosphate receptor subunits.J. Biol. Chem.27014700–14704. 10.1074/jbc.270.24.14700
72
MuchowskaK. B.VarmaS. J.MoranJ. (2020). Nonenzymatic metabolic reactions and life’s origins.Chem. Rev.1207708–7744. 10.1021/acs.chemrev.0c00191
73
NakadeS.MaedaN.MikoshibaK. (1991). Involvement of the C-terminus of the inositol 1,4,5-trisphosphate receptor in Ca2+ release analysed using region-specific monoclonal antibodies.Biochem. J.277125–131. 10.1042/bj2770125
74
NakagawaT.OkanoH.FuruichiT.ArugaJ.MikoshibaK. (1991). The subtypes of the mouse inositol 1,4,5-trisphosphate receptor are expressed in a tissue-specific and developmentally specific manner.Proc. Natl. Acad. Sci. U.S.A.886244–6248. 10.1073/pnas.88.14.6244
75
NakamuraY.FukamiK. (2017). Regulation and physiological functions of mammalian phospholipase C.J. Biochem.161315–321. 10.1093/jb/mvw094
76
NarayananD.AdebiyiA.JaggarJ. H. (2012). Inositol trisphosphate receptors in smooth muscle cells.Am. J. Physiol. Hear. Circ. Physiol.302H2190–H2210. 10.1152/ajpheart.01146.2011
77
NurminskayaM. V.BelkinA. M. (2012). Cellular functions of tissue transglutaminase.Int. Rev. Cell Mol. Biol.2941–97. 10.1016/B978-0-12-394305-7.00001-X
78
OkekeE.ParkerT.DingsdaleH.ConcannonM.AwaisM.VoroninaS.et al (2016). Epithelial-mesenchymal transition, IP3 receptors and ER-PM junctions: translocation of Ca2+ signalling complexes and regulation of migration.Biochem. J.473757–767. 10.1042/BJ20150364
79
PalmieriM.ImpeyS.KangH.di RonzaA.PelzC.SardielloM.et al (2011). Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways.Hum. Mol. Genet.203852–3866. 10.1093/hmg/ddr306
80
ParysJ. B.De SmedtH. (2012). Inositol 1,4,5-trisphosphate and its receptors.Adv. Exp. Med. Biol.740255–279. 10.1007/978-94-007-2888-2_11
81
PattersonR. L.BoehningD.SnyderS. H. (2004). Inositol 1,4,5-trisphosphate receptors as signal integrators.Annu. Rev. Biochem.73437–465. 10.1146/annurev.biochem.73.071403.161303
82
PengW.WongY. C.KraincD. (2020). Mitochondria-lysosome contacts regulate mitochondrial Ca2+ dynamics via lysosomal TRPML1.Proc. Natl. Acad. Sci. U.S.A.11719266–19275. 10.1073/pnas.2003236117
83
PerciavalleR. M.StewartD. P.KossB.LynchJ.MilastaS.BathinaM.et al (2012). Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration.Nat. Cell Biol.14575–583. 10.1038/ncb2488
84
PierroC.CookS. J.FoetsT. C. F.BootmanM. D.RoderickH. L. (2014). Oncogenic K-Ras suppresses IP3-dependent Ca2+ release through remodelling of the isoform composition of IP3Rs and ER luminal Ca2+levels in colorectal cancer cell lines.J. Cell Sci.1271607–1619. 10.1242/jcs.141408
85
PrinzW. A.ToulmayA.BallaT. (2020). The functional universe of membrane contact sites.Nat. Rev. Mol. Cell Biol.217–24. 10.1038/s41580-019-0180-9
86
ProleD. L.TaylorC. W. (2019). Structure and function of IP3 receptors.Cold Spring Harb. Perspect. Biol.11:a035063. 10.1101/cshperspect.a035063
87
PulliI.LassilaT.PanG.YanD.OlkkonenV. M.TörnquistK. (2018). Oxysterol-binding protein related-proteins (ORPs) 5 and 8 regulate calcium signaling at specific cell compartments.Cell Calc.7262–69. 10.1016/j.ceca.2018.03.001
88
RabinowitzJ. D.WhiteE. (2010). Autophagy and metabolism.Science3301344–1348. 10.1126/science.1193497
89
RezuchovaI.HudecovaS.SoltysovaA.MatuskovaM.DurinikovaE.ChovancovaB.et al (2019). Type 3 inositol 1,4,5-trisphosphate receptor has antiapoptotic and proliferative role in cancer cells.Cell Death Dis.10:186. 10.1038/s41419-019-1433-4
90
RochinL.SauvanetC.JääskeläinenE.HoucineA.KiveläA.XingjieM. A.et al (2019). Orp5 transfers phosphatidylserine to mitochondria and regulates mitochondrial calcium uptake at endoplasmic reticulum–mitochondria contact sites.bioRxiv [Preprint]. 10.1101/695577
91
RohwerN.BindelF.GrimmC.LinS. J.WapplerJ.KlingerB.et al (2016). Annexin A1 sustains tumor metabolism and cellular proliferation upon stable loss of HIF1A.Oncotarget76693–6710. 10.18632/oncotarget.6793
92
RosaN.SneyersF.ParysJ. B.BultynckG. (2020). Type 3 IP3 receptors: the chameleon in cancer.Int. Rev. Cell Mol. Biol.351101–148. 10.1016/bs.ircmb.2020.02.003
93
SakakuraC.HagiwaraA.FukudaK.ShimomuraK.TakagiT.KinS.et al (2003). Possible involvement of inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers.Anticancer Res.233691–3697.
94
SciacovelliM.FrezzaC. (2016). Oncometabolites: unconventional triggers of oncogenic signalling cascades.Free Radic. Biol. Med.100175–181. 10.1016/j.freeradbiomed.2016.04.025
95
ScorranoL.De MatteisM. A.EmrS.GiordanoF.HajnóczkyG.KornmannB.et al (2019). Coming together to define membrane contact sites.Nat. Commun.10:1287. 10.1038/s41467-019-09253-3
96
SeryshevaI. I. (2014). Toward a high-resolution structure of IP3R channel.Cell Calc.56125–132. 10.1016/j.ceca.2014.08.002
97
ShkrylV. M. (2017). Intracellular calcium fluxes in excitable cells.Neurophysiology49384–392. 10.1007/s11062-018-9698-2
98
Silva-PavezE.Ahumada-CastroU.LovyA.CárdenasJ. C. (2020). Ca2+ transfer to mitochondria: a spark of life in unexpected conditions.Mol. Cell. Oncol.8:1839341. 10.1080/23723556.2020.1839341
99
SinghA.SharmaR. K.ChagtooM.AgarwalG.GeorgeN.SinhaN.et al (2017). 1H NMR metabolomics reveals association of high expression of inositol 1, 4, 5 trisphosphate receptor and metabolites in breast cancer patients.PLoS One12:e0169330. 10.1371/journal.pone.0169330
100
SzabadkaiG.BianchiK.VárnaiP.De StefaniD.WieckowskiM. R.CavagnaD.et al (2006). Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels.J. Cell Biol.175901–911. 10.1083/jcb.200608073
101
SzadoT.VanderheydenV.ParysJ. B.De SmedtH.RietdorfK.KotelevetsL.et al (2008). Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis.Proc. Natl. Acad. Sci. U.S.A.1052427–2432. 10.1073/pnas.0711324105
102
TomarD.JañaF.DongZ.QuinnW. J.JadiyaP.BrevesS. L.et al (2019). Blockade of MCU-mediated Ca 2+ uptake perturbs lipid metabolism via PP4-dependent AMPK dephosphorylation.Cell Rep.263709–3725. 10.1016/j.celrep.2019.02.107
103
TuH.WangZ.BezprozvannyI. (2005). Modulation of mammalian inositol 1,4,5-trisphosphate receptor isoforms by calcium: a role of calcium sensor region.Biophys. J.881056–1069. 10.1529/biophysj.104.049601
104
UchidaK.MiyauchiH.FuruichiT.MichikawaT.MikoshibaK. (2003). Critical regions for activation gating of the inositol 1,4,5-trisphosphate receptor.J. Biol. Chem.27816551–16560. 10.1074/jbc.M300646200
105
VaisH.WangM.MallilankaramanK.PayneR.McKennanC.LockJ. T.et al (2020). ER-luminal [ca2+] regulation of insp3 receptor gating mediated by an er-luminal peripheral ca2+-binding protein.eLife9:e53531. 10.7554/eLife.53531
106
Van Der KantR.NeefjesJ. (2014). Small regulators, major consequences-Ca2+ and cholesterol at the endosome-ER interface.J. Cell Sci.127929–938. 10.1242/jcs.137539
107
VenkatesanS.SwantonC. (2016). Tumor evolutionary principles: how intratumor heterogeneity influences cancer treatment and outcome.Am. Soc. Clin. Oncol. Educ. B.35e141–e149. 10.1200/edbk_158930
108
VermassenE.ParysJ. B.MaugerJ. P. (2004). Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants.Biol. Cell963–17. 10.1016/j.biolcel.2003.11.004
109
VervloessemT.YuleD. I.BultynckG.ParysJ. B. (2014). The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca2+-release channel.Biochim. Biophys. Acta - Mol. Cell Res.18531992–2005. 10.1016/j.bbamcr.2014.12.006
110
VicencioJ. M.OrtizC.CriolloA.JonesA. W. E.KeppO.GalluzziL.et al (2009). The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1.Cell Death Differ.161006–1017. 10.1038/cdd.2009.34
111
WagnerL. E.YuleD. I. (2012). Differential regulation of the InsP3 receptor type-1 and -2 single channel properties by InsP3, Ca2+ and ATP.J. Physiol.5903245–3259. 10.1113/jphysiol.2012.228320
112
WardP. S.ThompsonC. B. (2012). Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.Cancer Cell21297–308. 10.1016/j.ccr.2012.02.014
113
WhiteC.LiC.YangJ.PetrenkoN. B.MadeshM.ThompsonC. B.et al (2005). The endoplasmic reticulum gateway to apoptosis by Bcl-XL modulation of the InsP3R.Nat. Cell Biol.71021–1028. 10.1038/ncb1302
114
WojcikiewiczR. J. H. (1995). Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types.J. Biol. Chem.27011678–11683. 10.1074/jbc.270.19.11678
115
WuH.CarvalhoP.VoeltzG. K. (2018). Here, there, and everywhere: the importance of ER membrane contact sites.Science361:eaan5835. 10.1126/science.aan5835
116
YangJ.ZhaoZ.GuM.FengX.XuH. (2019). Release and uptake mechanisms of vesicular Ca 2+ stores.Protein Cell108–19. 10.1007/s13238-018-0523-x
117
ZajacA. L.GoldmanY. E.HolzbaurE. L. F.OstapE. M. (2013). Local cytoskeletal and organelle interactions impact molecular-motor-driven early endosomal trafficking.Curr. Biol.231173–1180. 10.1016/j.cub.2013.05.015
118
ZhaiX.StereaA. M.El HianiY. (2020). Lessons from the endoplasmic reticulum Ca2+ transporters-a cancer connection.Cells9:1536. 10.3390/cells9061536
119
ZhongW.XuM.LiC.ZhuB.CaoX.LiD.et al (2019). ORP4L extracts and presents PIP 2 from plasma membrane for PLCβ3 catalysis: targeting it eradicates leukemia stem cells.Cell Rep.262166–2177. 10.1016/j.celrep.2019.01.082
Summary
Keywords
IP3Rs, calcium, endoplasmic reticulum, mitochondria, lysosome, metabolism, inositol triphosphate (IP3) receptors
Citation
Ahumada-Castro U, Bustos G, Silva-Pavez E, Puebla-Huerta A, Lovy A and Cárdenas C (2021) In the Right Place at the Right Time: Regulation of Cell Metabolism by IP3R-Mediated Inter-Organelle Ca2+ Fluxes. Front. Cell Dev. Biol. 9:629522. doi: 10.3389/fcell.2021.629522
Received
15 November 2020
Accepted
19 January 2021
Published
02 March 2021
Volume
9 - 2021
Edited by
Saverio Marchi, Marche Polytechnic University, Italy
Reviewed by
Riccardo Filadi, Institute of Neuroscience, National Research Council (CNR), Italy; Giovanni Monaco, CISTIM, Belgium
Updates
Copyright
© 2021 Ahumada-Castro, Bustos, Silva-Pavez, Puebla-Huerta, Lovy and Cárdenas.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ulises Ahumada-Castro, ulises.ahumada@mayor.cl; uj.ahumada@gmail.comCésar Cárdenas, julio.cardenas@umayor.cl
This article was submitted to Signaling, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.